Skip to main content
Have a personal or library account? Click to login

References

  1. Wu J, Mamas MA, Mohamed MO, et al. Place and causes of acute cardiovascular mortality during the COVID-19 pandemic. Heart. 2020; heartjnl-2020-317912. DOI: 10.1136/heartjnl-2020-317912
  2. Rossen LM, Gold JAW, Ahmad FB, Sutton PD, Branum AM. Trends in the distribution of COVID-19 deaths by age and race/ethnicity — United States, April 4–December 26, 2020. Ann Epidemiol. 2021; 62: 668. DOI: 10.1016/j.annepidem.2021.06.003
  3. Baqui P, Bica I, Marra V, Ercole A, van der Schaar M. Ethnic and regional variations in hospital mortality from COVID-19 in Brazil: A cross-sectional observational study. Lancet Glob Health. 2020; 8: e101826. DOI: 10.1016/S2214-109X(20)30285-0
  4. Liu L, Wang D, Brainin M, Elkind MSV, Leira E, Wang Y. Approaches to global stroke care during the COVID-19 pandemic. Stroke Vasc Neurol. 2020; 5: 1079. DOI: 10.1136/svn-2020-000429
  5. Richardson S, Hirsch JS, Narasimhan M, et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA. 2020; 323: 20529. DOI: 10.1001/jama.2020.6775
  6. Banerjee A, Chen S, Pasea L, et al. Excess deaths in people with cardiovascular diseases during the COVID-19 pandemic. Eur J Prev Cardiol. 2021; zwaa155. DOI: 10.1093/eurjpc/zwaa155
  7. Alexander GC, Tajanlangit M, Heyward J, Mansour O, Qato DM, Stafford RS. Use and Content of Primary Care Office-Based vs Telemedicine Care Visits During the COVID-19 Pandemic in the US. JAMA Netw Open. 2020; 3: e2021476. DOI: 10.1001/jamanetworkopen.2020.21476
  8. Carr MJ, Wright AK, Leelarathna L, et al. Impact of COVID-19 on diagnoses, monitoring, and mortality in people with type 2 diabetes in the UK. Lancet Diabetes Endocrinol. 2021; 9: 4135. DOI: 10.1016/S2213-8587(21)00116-9
  9. Francis A, Baigent C, Ikizler TA, Cockwell P, Jha V. The urgent need to vaccinate dialysis patients against severe acute respiratory syndrome coronavirus 2: A call to action. Kidney Int. 2021; 99: 7913. DOI: 10.1016/j.kint.2021.02.003
  10. Choi EM. COVID-19 vaccines for low- and middle-income countries. Trans R Soc Trop Med Hyg. 2021; trab045. DOI: 10.1093/trstmh/trab045
  11. Martinez R, Lloyd-Sherlock P, Soliz P, et al. Trends in premature avertable mortality from non-communicable diseases for 195 countries and territories, 1990–2017: A population-based study. Lancet Glob Health. 2020; 8: e51123. DOI: 10.1016/S2214-109X(20)30035-8
  12. Li SL, Pereira RHM, Prete CA, Jr., et al. Higher risk of death from COVID-19 in low-income and non-White populations of São Paulo, Brazil. BMJ Glob Health. 2021; 6: e004959. DOI: 10.1136/bmjgh-2021-004959
  13. Miller BL. Science Denial and COVID Conspiracy Theories: Potential Neurological Mechanisms and Possible Responses. JAMA. 2020; 324: 22556. DOI: 10.1001/jama.2020.21332
  14. Malta M, Vettore MV, da Silva CMFP, Silva AB, Strathdee SA. Political neglect of COVID-19 and the public health consequences in Brazil: The high costs of science denial. EClinicalMedicine. 2021; 35: 100878. DOI: 10.1016/j.eclinm.2021.100878
  15. Machado Silva H. The Brazilian Scientific Denialism Through The American Journal of Medicine. The American Journal of Medicine. 2021; 134: 4156. DOI: 10.1016/j.amjmed.2021.01.003
  16. Borba MGS, Val FFA, Sampaio VS, et al. Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Randomized Clinical Trial. JAMA Network Open. 2020; 3: e208857e208857. DOI: 10.1001/jamanetworkopen.2020.8857
  17. Alwan NA, Burgess RA, Ashworth S, et al. Scientific consensus on the COVID-19 pandemic: We need to act now. Lancet. 2020; 396: e712. DOI: 10.1016/S0140-6736(20)32153-X
  18. Visseren FLJ, Mach F, Smulders YM, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice: Developed by the Task Force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies With the special contribution of the European Association of Preventive Cardiology (EAPC). European Heart Journal. 2021; 42: 3227337. DOI: 10.1093/eurheartj/ehab484
  19. Williamson EJ, Walker AJ, Bhaskaran K, et al. OpenSAFELY: Factors associated with COVID-19 death in 17 million patients. Nature. 2020; 584: 4306. DOI: 10.1038/s41586-020-2521-4
  20. Gibertoni D, Reno C, Rucci P, et al. COVID-19 incidence and mortality in non-dialysis chronic kidney disease patients. PLoS One. 2021; 16: e0254525. DOI: 10.1371/journal.pone.0254525
  21. Mai F, Del Pinto R, Ferri C. COVID-19 and cardiovascular diseases. J Cardiol. 2020; 76: 4538. DOI: 10.1016/j.jjcc.2020.07.013
  22. Singh AK, Khunti K. Assessment of risk, severity, mortality, glycemic control and antidiabetic agents in patients with diabetes and COVID-19: A narrative review. Diabetes Res Clin Pract. 2020; 165: 108266. DOI: 10.1016/j.diabres.2020.108266
  23. Clift AK, Coupland CAC, Keogh RH, et al. Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from coronavirus 19 in adults: National derivation and validation cohort study. BMJ. 2020; 371: m3731. DOI: 10.1136/bmj.m3731
  24. Pifarré i Arolas H, Vidal-Alaball J, Gil J, López F, Nicodemo C, Saez M. Missing Diagnoses during the COVID-19 Pandemic: A Year in Review. Int J Environ Res Public Health. 2021; 18: 5335. DOI: 10.3390/ijerph18105335
  25. Roy CM, Bollman EB, Carson LM, Northrop AJ, Jackson EF, Moresky RT. Assessing the indirect effects of COVID-19 on healthcare delivery, utilization and health outcomes: A scoping review. Eur J Public Health. 2021; ckab047. DOI: 10.1093/eurpub/ckab047
  26. Rennert-May E, Leal J, Thanh NX, et al. The impact of COVID-19 on hospital admissions and emergency department visits: A population-based study. PLoS One. 2021; 16: e0252441. DOI: 10.1371/journal.pone.0252441
  27. Hussein NR, Saleem MZS, Ibrahim N, Musa DH, Naqid IA. The impact of COVID-19 pandemic on the care of patients with kidney diseases in Duhok City, Kurdistan Region of Iraq. Diabetes Metab Syndr. 2020; 14: 15513. DOI: 10.1016/j.dsx.2020.08.013
  28. Prasad N, Bhatt M, Agarwal SK, et al. The Adverse Effect of COVID Pandemic on the Care of Patients With Kidney Diseases in India. Kidney Int Rep. 2020; 5: 154550. DOI: 10.1016/j.ekir.2020.06.034
  29. Sung HK, Paik JH, Lee YJ, Kang S. Impact of the COVID-19 Outbreak on Emergency Care Utilization in Patients with Acute Myocardial Infarction: A Nationwide Population-based Study. J Korean Med Sci. 2021; 36: e111. DOI: 10.3346/jkms.2021.36.e111
  30. Rostoker G, Issad B, Fessi H, Massy ZA. Why and how should we promote home dialysis for patients with end-stage kidney disease during and after the coronavirus 2019 disease pandemic? A French perspective. J Nephrol. 2021; 15. DOI: 10.1007/s40620-021-01061-7
  31. Sankaranarayanan R, Hartshorne-Evans N, Redmond-Lyon S, et al. The impact of COVID-19 on the management of heart failure: a United Kingdom patient questionnaire study. ESC Heart Fail. 2021; 8: 132432. DOI: 10.1002/ehf2.13209
  32. Schwartz JI, Muddu M, Kimera I, et al. Impact of a COVID-19 National Lockdown on Integrated Care for Hypertension and HIV. Glob Heart. n.d.; 16: 9. DOI: 10.5334/gh.928
  33. Singh K, Kaushik A, Johnson L, et al. Patient experiences and perceptions of chronic disease care during the COVID-19 pandemic in India: A qualitative study. BMJ Open. 2021; 11: e048926. DOI: 10.1136/bmjopen-2021-048926
  34. Ran J, Zhao S, Han L, et al. Increase in Diabetes Mortality Associated With COVID-19 Pandemic in the U.S. Diabetes Care. 2021; 44: e1467. DOI: 10.2337/dc21-0213
  35. Bress AP, Cohen JB, Anstey DE, et al. Inequities in Hypertension Control in the United States Exposed and Exacerbated by COVID-19 and the Role of Home Blood Pressure and Virtual Health Care During and After the COVID-19 Pandemic. Journal of the American Heart Association. 2021; 10: e020997. DOI: 10.1161/JAHA.121.020997
  36. Hook JN, Davis DE, Owen J, Worthington EL, Jr., Utsey SO. Cultural humility: Measuring openness to culturally diverse clients. Journal of Counseling Psychology. 2013; 60: 35366. DOI: 10.1037/a0032595
  37. World Health Organization. The ACT-Accelerator Frequently Asked Questions [Internet]. World Health Organization. [cited 2021 Aug 21]. Available from: https://www.who.int/initiatives/act-accelerator/faq.
  38. Combe C, Kirsch AH, Alfano G, et al. At least 156 reasons to prioritize COVID-19 vaccination in patients receiving in-centre haemodialysis. Nephrol Dial Transplant. 2021; gfab007. DOI: 10.1093/ndt/gfab007
  39. Silvariño R, Ferreiro A, Seija M, et al. Recomendaciones sobre la vacunación contra SARS-CoV-2/COVID-19 en pacientes con enfermedad renal y trasplante renal. Revista Médica Del Uruguay. 2021; 37. DOI: 10.29193/RMU.37.2.11
  40. World Health Organization. WHO Resolution - Strengthening local production of medicines and other health technologies to improve access [Internet]. World Health Organization. [cited 2021 Aug 21]. Available from: https://apps.who.int/gb/ebwha/pdf_files/WHA74/A74_R6-en.pdf.
  41. Temesgen ZM, DeSimone DC, Mahmood M, Libertin CR, Varatharaj Palraj BR, Berbari EF. Health Care After the COVID-19 Pandemic and the Influence of Telemedicine. Mayo Clin Proc. 2020; 95: S668. DOI: 10.1016/j.mayocp.2020.06.052
  42. Eberly LA, Khatana SAM, Nathan AS, et al. Telemedicine Outpatient Cardiovascular Care During the COVID-19 Pandemic. Circulation. 2020; 142: 5102. DOI: 10.1161/CIRCULATIONAHA.120.048185
  43. Agyemang-Duah W, Peprah C, Peprah P. Barriers to formal healthcare utilisation among poor older people under the livelihood empowerment against poverty programme in the Atwima Nwabiagya District of Ghana. BMC Public Health. 2019; 19: 1185. DOI: 10.1186/s12889-019-7437-2
  44. Yuan N, Pevnick JM, Botting PG, et al. Patient Use and Clinical Practice Patterns of Remote Cardiology Clinic Visits in the Era of COVID-19. JAMA Network Open. 2021; 4: e214157e214157. DOI: 10.1001/jamanetworkopen.2021.4157
  45. Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: Meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. Centre for Reviews and Dissemination (UK); 2009. DOI: 10.1136/bmj.b1665
  46. Rothwell PM, Coull AJ, Giles MF, et al. Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study). Lancet. 2004; 363: 192533. DOI: 10.1016/S0140-6736(04)16405-2
  47. Falaschetti E, Mindell J, Knott C, Poulter N. Hypertension management in England: A serial cross-sectional study from 1994 to 2011. The Lancet. 2014; 383: 19129. DOI: 10.1016/S0140-6736(14)60688-7
  48. Intercollegiate Stroke Working Party. National Clinial Guideline for Stroke [Internet]. Royal College of Physicians; 2016 [cited 2021 Aug 21]. Available from: https://www.strokeaudit.org/SupportFiles/Documents/Guidelines/2016-National-Clinical-Guideline-for-Stroke-5t-(1).aspx.
  49. Unger T, Borghi C, Charchar F, et al. 2020 International Society of Hypertension global hypertension practice guidelines. J Hypertens. 2020; 38: 9821004. DOI: 10.1097/HJH.0000000000002453
  50. Jamison J, Graffy J, Mullis R, Mant J, Sutton S. Stroke survivors’, caregivers’ and GPs’ attitudes towards a polypill for the secondary prevention of stroke: A qualitative interview study. BMJ Open. 2016; 6: e010458. DOI: 10.1136/bmjopen-2015-010458
  51. De Simoni A, Hardeman W, Mant J, Farmer AJ, Kinmonth AL. Trials to Improve Blood Pressure Through Adherence to Antihypertensives in Stroke/TIA: Systematic Review and Meta-Analysis. J Am Heart Assoc. 2013; 2: e000251. DOI: 10.1161/JAHA.113.000251
  52. Phillips LS, Branch WT, Cook CB, et al. Clinical inertia. Ann Intern Med. 2001; 135: 82534. DOI: 10.7326/0003-4819-135-9-200111060-00012
  53. Glynn LG, Murphy AW, Smith SM, Schroeder K, Fahey T. Interventions used to improve control of blood pressure in patients with hypertension. Cochrane Database Syst Rev. 2010; CD005182. DOI: 10.1002/14651858.CD005182.pub4
  54. De Simoni A, Mant J, Sutton S. Adherence to medication in stroke survivors dependent on caregivers. Br J Gen Pract. 2015; 65: e789791. DOI: 10.3399/bjgp15X687589
  55. Fletcher BR, Hinton L, Hartmann-Boyce J, Roberts NW, Bobrovitz N, McManus RJ. Self-monitoring blood pressure in hypertension, patient and provider perspectives: A systematic review and thematic synthesis. Patient Educ Couns. 2016; 99: 2109. DOI: 10.1016/j.pec.2015.08.026
  56. Fleming DM, Cross KW, Barley MA. Recent changes in the prevalence of diseases presenting for health care. Br J Gen Pract. 2005; 55: 58995.
  57. Hobbs FDR, Bankhead C, Mukhtar T, et al. Clinical workload in UK primary care: A retrospective analysis of 100 million consultations in England, 2007–14. Lancet. 2016; 387: 232330. DOI: 10.1016/S0140-6736(16)00620-6
  58. McManus RJ, Mant J, Bray EP, et al. Telemonitoring and self-management in the control of hypertension (TASMINH2): A randomized controlled trial. Lancet. 2010; 376: 16372. DOI: 10.1016/S0140-6736(10)60964-6
  59. McManus RJ, Mant J, Haque MS, et al. Effect of self-monitoring and medication self-titration on systolic blood pressure in hypertensive patients at high risk of cardiovascular disease: The TASMIN-SR randomized clinical trial. JAMA. 2014; 312: 799808. DOI: 10.1001/jama.2014.10057
  60. McKinstry B, Hanley J, Wild S, et al. Telemonitoring based service redesign for the management of uncontrolled hypertension: Multicentre randomized controlled trial. BMJ. 2013; 346: f3030. DOI: 10.1136/bmj.f3030
  61. Bray EP, Jones MI, Banting M, et al. Performance and persistence of a blood pressure self-management intervention: Telemonitoring and self-management in hypertension (TASMINH2) trial. J Hum Hypertens. 2015; 29: 43641. DOI: 10.1038/jhh.2014.108
  62. Ward AM, Takahashi O, Stevens R, Heneghan C. Home measurement of blood pressure and cardiovascular disease: Systematic review and meta-analysis of prospective studies. J Hypertens. 2012; 30: 44956. DOI: 10.1097/HJH.0b013e32834e4aed
  63. Hanley J, Fairbrother P, Krishan A, et al. Mixed methods feasibility study for a trial of blood pressure telemonitoring for people who have had stroke/transient ischaemic attack (TIA). Trials. 2015; 16: 117. DOI: 10.1186/s13063-015-0628-y
  64. Ofcom. Adults’ media use and attitudes [Internet]. Ofcom. [cited 2021 Aug 21]. Available from: https://www.ofcom.org.uk/research-and-data/media-literacy-research/adults/adults-media-use-and-attitudes.
  65. Tomaszewski M, White C, Patel P, et al. High rates of non-adherence to antihypertensive treatment revealed by high-performance liquid chromatography-tandem mass spectrometry (HP LC-MS/MS) urine analysis. Heart. 2014; 100: 85561. DOI: 10.1136/heartjnl-2013-305063
  66. Nuclear Threat Initiative, Johns Hopkins Center for Health Security, The Economist Intelligence Unit. The Global Health Security Index [Internet]. Global Health Security Index. 2019 [cited 2021 Aug 21]. Available from: https://www.ghsindex.org/.
  67. Chaloupka FJ, Powell LM, Warner KE. The Use of Excise Taxes to Reduce Tobacco, Alcohol, and Sugary Beverage Consumption. Annu Rev Public Health. 2019; 40: 187201. DOI: 10.1146/annurev-publhealth-040218-043816
  68. Summan A, Stacey N, Birckmayer J, Blecher E, Chaloupka FJ, Laxminarayan R. The potential global gains in health and revenue from increased taxation of tobacco, alcohol and sugar-sweetened beverages: A modelling analysis. BMJ Glob Health. 2020; 5: e002143. DOI: 10.1136/bmjgh-2019-002143
  69. International Monetary Fund. World Economic Outlook: Managing Divergent Recoveries. Washington, DC, April. 2021. https://www.imf.org/en/Publications/WEO/Issues/2021/03/23/world-economic-outlook-april-2021.
  70. Lane C, Glassman A, Smitham E. Using Health Taxes to Support Revenue: An Action Agenda for the IMF and World Bank [Internet]. Center for Global Development; 2021 [cited 2021 Aug 21]. Available from: https://www.cgdev.org/sites/default/files/Lane-Health-Tax-COVID-19.pdf.
  71. Ozer C, Bloom D, Martinez Valle A, et al. Health earmarks and health taxes: What do we know? n.d.
  72. Horton R. Offline: COVID-19 is not a pandemic. The Lancet. 2020; 396: 874. DOI: 10.1016/S0140-6736(20)32000-6
  73. Ng WH, Tipih T, Makoah NA, et al. Comorbidities in SARS-CoV-2 Patients: A Systematic Review and Meta-Analysis. MBio. n.d.; 12: e0364720. DOI: 10.1128/mBio.03647-20
  74. Ahmad FB, Cisewski JA, Miniño A, Anderson RN. Provisional Mortality Data — United States, 2020 | MMWR; n.d. https://www.cdc.gov/mmwr/volumes/70/wr/mm7014e1.htm (accessed 21 August 2021). DOI: 10.15585/mmwr.mm7014e1
DOI: https://doi.org/10.5334/gh.1077 | Journal eISSN: 2211-8179
Language: English
Submitted on: Sep 27, 2021
Accepted on: Sep 27, 2021
Published on: Oct 12, 2021
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2021 The Global Coalition for Circulatory Health, Leslie Rae Ferat, Ryan Forrest, Kawaldip Sehmi, Raul D. Santos, David Stewart, Andrew J. M. Boulton, Beatriz Yáñez Jiménez, Phil Riley, Dylan Burger, Erika S. W. Jones, Maciej Tomaszewski, Maria Rita Milanese, Paul Laffin, Vivekanand Jha, Bettina Borisch, Michael Moore, Fausto J. Pinto, Daniel Piñeiro, Jean-Luc Eiselé, Daniel T. Lackland, Paul K. Whelton, Xin-Hua Zhang, Anna Stavdal, Donald Li, Richard Hobbs, Jeyaraj Durai Pandian, Michael Brainin, Valery Feigin, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.